VPS25 and neoplasm: In this study, the overexpression of VPS25 in the high-risk group (Fig. 4C) promoted the formation of ESCRT-II and delayed or prevented the necrotic apoptosis of tumor cells, thus contributed to worse OS in high-risk groups (Fig. 4D).